Loading…
Underlying
Underlying Price
$0.51
Type
Call
Strike
2
Expiration
Nov 20, 2026
DTE
26d
Moneyness
OTM
Intrinsic
$0.00
JSPR 2 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Nov 20, 2026 | 26d | — | — | 0 | 0 |
| Dec 18, 2026 | 54d | $0.15 | +66.67% | 10 | 196 |
| Jan 15, 2027 | 82d | $0.10 | -60.00% | 2 | 6 |
| Apr 16, 2027 | 173d | $0.05 | -54.55% | 1 | 316 |
JSPR Profile
jasper therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. jasper's lead compound, jsp191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.